AACR Journals Most Cited 2010 Papers
 |
AACR is pleased to announce the most cited 2010 research articles published in the AACR journals. These research articles published in 2010 are selected based on the total number of citations from the publication date. AACR congratulates the authors of these research articles.
Most Cited 2010 Article in Cancer Research
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta, Barry R. Davies, Ian Hickson, Tom Harding, Sabina Cosulich, Susan E. Critchlow, John P. Vincent, Rebecca Ellston, Darren Jones, Patrizia Sini, Dominic James, Zoe Howard, Phillippa Dudley, Gareth Hughes, Lisa Smith, Sharon Maguire, Marc Hummersone, Karine Malagu, Keith Menear, Richard Jenkins, Matt Jacobsen, Graeme C.M. Smith, Sylvie Guichard, and Martin Pass
Cancer Res January 1, 2010 70:288-298; Published OnlineFirst December 22, 2009
doi:10.1158/0008-5472.CAN-09-1751
http://cancerres.aacrjournals.org/content/70/1/288.abstract
Most Cited 2010 Article in Clinical Cancer Research
Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark Diebel, Benjamin Esterni, Gilles Houvenaeghel, Jean-Marc Extra, François Bertucci, Jocelyne Jacquemier, Luc Xerri, Gabriela Dontu, Giorgio Stassi, Yi Xiao, Sanford H. Barsky, Daniel Birnbaum, Patrice Viens, and Max S. Wicha
Clin Cancer Res January 1, 2010 16:45-55; Published OnlineFirst December 22, 2009
doi:10.1158/1078-0432.CCR-09-1630
http://clincancerres.aacrjournals.org/content/16/1/45.abstract
Most Cited 2010 Article in Cancer Epidemiology, Biomarkers & Prevention
Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population
DeAnn Lazovich, Rachel Isaksson Vogel, Marianne Berwick, Martin A. Weinstock, Kristin E. Anderson, and Erin M. Warshaw
Cancer Epidemiol Biomarkers Prev June 2010 19:1557-1568; Published OnlineFirst May 26, 2010
doi:10.1158/1055-9965.EPI-09-1249
http://cebp.aacrjournals.org/content/19/6/1557.abstract
Most Cited 2010 Article in Molecular Cancer Therapeutics
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, Katsuyoshi Miyama, Shunsuke Taguchi, Kyoko Tsujioka, Yoko Ueno, Harold Hatch, Pradip K. Majumder, Bo-Sheng Pan, and Hidehito Kotani
Mol Cancer Ther July 2010 9:1956-1967; Published OnlineFirst June 22, 2010
doi:10.1158/1535-7163.MCT-09-1012
http://mct.aacrjournals.org/content/9/7/1956.abstract
Most Cited 2010 Article in Molecular Cancer Research
Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes
Hui-Wen Lo, Xinyu Cao, Hu Zhu, and Francis Ali-Osman
Mol Cancer Res February 2010 8:232-245; Published OnlineFirst February 9, 2010
doi:10.1158/1541-7786.MCR-09-0391
http://mcr.aacrjournals.org/content/8/2/232.abstract
Most Cited 2010 Article in Cancer Prevention Research
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Reena S. Cecchini, James N. Atkins, Therese B. Bevers, Louis Fehrenbacher, Eduardo R. Pajon, James L. Wade III, André Robidoux, Richard G. Margolese, Joan James, Carolyn D. Runowicz, Patricia A. Ganz, Steven E. Reis, Worta McCaskill-Stevens, Leslie G. Ford, V. Craig Jordan, and Norman Wolmark , for the National Surgical Adjuvant Breast and Bowel Project
Cancer Prev Res June 2010 3:696-706; Published OnlineFirst April 19, 2010
doi:10.1158/1940-6207.CAPR-10-0076
http://cancerpreventionresearch.aacrjournals.org/content/3/6/696.abstract
